March 2023

Al Center, San Francisco, CA, and approved April 9, 2021 (received for critique December four, 2020)The cancer-free photosensitive trichothiodystrophy (PS-TTD) and the cancer-prone xeroderma pigmentosum (XP) are uncommon monogenic problems…